Bruker Corporation to Present at Investor Conferences
May 07 2021 - 7:00AM
Business Wire
Bruker Corporation (Nasdaq: BRKR) announced today it will
participate in the following virtual conferences:
BofA Securities 2021 Health Care Conference Tuesday, May
11, 2021, at 11:00 a.m. Eastern Time Frank Laukien, Chairman,
President and Chief Executive Officer Mark Munch, President, Bruker
Nano Group
UBS Global Healthcare Virtual Conference Monday, May 24,
2021, at 9:00 a.m. Eastern Time Frank Laukien, Chairman, President
and Chief Executive Officer Mark Munch, President, Bruker Nano
Group
Jefferies Virtual Healthcare Conference Wednesday, June
2, 2021, at 8:00 a.m. Eastern Time Frank Laukien, Chairman,
President and Chief Executive Officer Juergen Srega, President,
Bruker CALID Group
Live audio webcasts of the virtual presentation and “fireside”
sessions will be available on the Investor Relations section of the
Company's website at https://ir.bruker.com. Replays will be posted
on Bruker’s Investor Relations website after each event and will be
available for 30 days following the presentation.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker’s high performance scientific instruments and high
value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity and customer success in life
science molecular and cell biology research, in applied and pharma
applications, in microscopy and nanoanalysis, as well as in
industrial applications. Bruker offers differentiated, high-value
life science and diagnostics systems and solutions in preclinical
imaging, clinical phenomics research, proteomics and multiomics,
spatial and single-cell biology, functional structural and
condensate biology, as well as in clinical microbiology and
molecular diagnostics. For more information, please visit:
www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210507005145/en/
Miroslava Minkova Senior Director, Investor Relations &
Corporate Development Bruker Corporation T: +1 (978) 663 – 3660,
ext. 1479 E: Investor.Reations@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Apr 2023 to Apr 2024